⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
USP30 Inhibitors
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-09 — Cell-Type-Specific Calibration of Mitochondrial Ubiquitination in Stem Cell Fate Decisions.: 2025 review consolidates recent USP30 inhibitor co-crystal structures as enabling selective blockade of the mitochondrial deubiquitinase that opposes Parkin, situating USP30 within a cell-type-specific mitochondrial ubiquitination rheostat for stem-cell aging (mechanistic review, no clinical outcomes). [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Cell-Type-Specific Calibration of Mitochondrial Ubiquitination in Stem Cell Fate Decisions.
09-jul-2026
novelty 3
per-area 3
strengthens